News Alert

Novartis is Fifth Drugmaker to Sue HRSA to Implement Controversial 340B Rebate Model

Novartis is suing HRSA to impose a controversial 340B rebate model that the agency has not authorized.
Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NYT Investigative Article Sparks Both Scrutiny and Support for 340B Prime Vendor Apexus

The New York Times published a Jan. 15 investigative article about the 340B prime vendor.
Yesterday’s New York Times investigative article alleging that the 340B prime vendor, Apexus, profited by driving 340B program expansion has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Nebraska, New York Reintroduce 340B Contract Pharmacy Access Bills in 2025

Nebraska state Sen. Brian Hardin (left) and New York state Sen. Gustavo Rivera (right) each introduced 340B contract pharmacy access bills this week.
Lawmakers in Nebraska and New York have reintroduced 340B contract pharmacy access bills this week after their state legislatures failed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Terminates 20 ‘Ineligible’ 340B Sites from STD Clinic; Clinic Rejects Allegations and Vows to Fight Back

HRSA has terminated 20 Sagebrush Health sites from the 340B program for allegedly violating program eligibility requirements.
The Health Resources and Services Administration (HRSA) has terminated the 340B status of 20 sites affiliated with the Nevada-based STD [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Mexico is Third State to Introduce 340B Contract Pharmacy Access Bill in 2025

A New Mexico lawmaker prefiled legislation that would prohibit drugmakers from restricting 340B contract pharmacy access.
An influential New Mexico lawmaker is once again pushing to protect state 340B providers from drugmaker contract pharmacy restrictions after [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Missouri Bill Would Significantly Restrict Uses of 340B Savings, Add Provider Reporting Requirements

Missouri state Rep. Ben Keathley (R) introduced a bill that would only allow state providers to use 340B savings on uninsured patients.
A conservative Missouri state lawmaker has introduced a bill that would require state providers to direct all of their 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kentucky, Utah Introduce First Contract Pharmacy Access Bills of 2025

Kentucky Sen. Stephen Meredith (R), a former hospital CEO, introduced a 340B contract pharmacy access bill for the second straight year.
Influential Republican state senators in Kentucky and Utah have each introduced 340B contract pharmacy access bills to kick off their [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Appeals in Mississippi and Maryland; Update in Missouri

Key briefs were filed over the past few weeks in litigation over state contract pharmacy access laws in Mississippi, Maryland and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmaker Lawsuit Targets 340B Eligibility of In-Kind STD Clinics; STD Grantee Denies Allegations

Three drugmakers sued HRSA in federal court over 340B eligibility for certain STD clinics, including Sagebrush Health.
Three large drugmakers are suing the federal government for allegedly allowing certain STD clinics to unlawfully participate in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Urges CMS to Block Drugmaker 340B Rebate Models, Improve Medicare Transaction Facilitator

The AHA raised concerns that October 2024 federal guidance on Medicare drug price negotiations may allow drugmakers to “wrongly justify fundamental changes to the 340B program.”
A major hospital advocacy group recently warned that October 2024 agency guidance on Medicare drug price negotiations may allow drugmakers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live